Versant Venture Management as of June 30, 2025
Portfolio Holdings for Versant Venture Management
Versant Venture Management holds 8 positions in its portfolio as reported in the June 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Monte Rosa Therapeutics Common Stock (GLUE) | 31.0 | $26M | 5.7M | 4.51 | |
| CRISPR Therapeutics Common Shares (CRSP) | 29.5 | $24M | 499k | 48.64 | |
| Jade Biosciences Common Stock (JBIO) | 18.6 | $15M | 1.5M | 9.99 | |
| Skye Bioscience Common Stock (SKYE) | 10.2 | $8.4M | 2.0M | 4.18 | |
| Repare Therapeutics Common Stock (RPTX) | 4.5 | $3.7M | 2.6M | 1.39 | |
| Contineum Therapeutics Common Stock (CTNM) | 2.6 | $2.2M | 543k | 3.97 | |
| Tempest Therapeutics Common Stock | 2.2 | $1.8M | 270k | 6.80 | |
| Adverum Biotechnologies Common Stock | 1.3 | $1.1M | 507k | 2.15 |
